|Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies|
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
|Genome-wide association study identifies novel breast cancer susceptibility loci|
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
|Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations|
CHEK2-Breast Cancer Consortium
Nature genetics 31 (1), 55, 2002
|PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene|
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
|Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial|
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
|Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls|
N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ...
Nature 464 (7289), 713, 2010
|Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE|
N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ...
JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013
|Genome-wide association study identifies five new breast cancer susceptibility loci|
C Turnbull, S Ahmed, J Morrison, D Pernet, A Renwick, M Maranian, ...
Nature genetics 42 (6), 504-507, 2010
|Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles|
S Seal, D Thompson, A Renwick, A Elliott, P Kelly, R Barfoot, T Chagtai, ...
Nature genetics 38 (11), 1239-1241, 2006
|ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles|
A Renwick, D Thompson, S Seal, P Kelly, T Chagtai, M Ahmed, B North, ...
Nature genetics 38 (8), 873-875, 2006
|Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results|
SE Plon, DM Eccles, D Easton, WD Foulkes, M Genuardi, MS Greenblatt, ...
Human mutation 29 (11), 1282-1291, 2008
|Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies|
XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ...
Journal of the National Cancer Institute 103 (3), 250-263, 2011
|Association analysis identifies 65 new breast cancer risk loci|
K Michailidou, S Lindstr÷m, J Dennis, J Beesley, S Hui, S Kar, A Lemašon, ...
Nature 551 (7678), 92, 2017
|Newly discovered breast cancer susceptibility loci on 3p24 and 17q23. 2|
S Ahmed, G Thomas, M Ghoussaini, CS Healey, MK Humphreys, R Platte, ...
Nature genetics 41 (5), 585-590, 2009
|Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer|
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
|Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH|
JR Sampson, S Dolwani, S Jones, D Eccles, A Ellis, DG Evans, I Frayling, ...
The Lancet 362 (9377), 39-41, 2003
|Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer|
E Castro, C Goh, D Olmos
Journal of Clinical Oncology 31 (14), 1748, 2013
|The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions|
AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ...
British journal of cancer 98 (8), 1457-1466, 2008
|Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer|
FJ Couch, SN Hart, P Sharma, AE Toland, X Wang, P Miron, JE Olson, ...
Journal of clinical oncology 33 (4), 304, 2015
|Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)|
N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ...
Cancer Epidemiology and Prevention Biomarkers 21 (1), 134-147, 2012